Overview

Comparing Fetoscopic Surgery Protocols

Status:
Withdrawn

Trial end date:
2024-04-01

Target enrollment:

Participant gender:

Summary

Determine surgeon and patient satisfaction with remifentanil-dexmedetomidine (REMI) and dexmedetomidine-fentanyl (DEX) sedation protocols in pregnant patients undergoing minimally invasive fetoscopic procedures

Phase:

N/A

Details

Lead Sponsor:

Children's Hospital Medical Center, Cincinnati

Treatments:

Dexmedetomidine
Fentanyl
Remifentanil